For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

The Rogosin Institute

USPTO Granted Patents = 22

% Expired Patents = 13.6

CIPO Patents = 1

EPO Patents = 7

Forward Citations = 208

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Albert L Rubin (17 out of 25 patents)

Barry H Smith (16 out of 19 patents)

Kanti Jain (9 out of 10 patents)

4. Kurt Stenzel (7 out of 8 patents)

5. Lawrence Gazda (6 out of 6 patents)

6. Daniel M Levine (6 out of 10 patents)

7. Thomas S Parker (6 out of 7 patents)

8. Shirin Asina (6 out of 7 patents)

9. Bruce R Gordon (5 out of 6 patents)

10. Stuart D Saal (5 out of 6 patents)

11. Melissa Laramore (2 out of 2 patents)

12. Timothy Hamilton (2 out of 2 patents)

13. Bryan Conn (1 out of 1 patent)

14. Sanford R Simon (1 out of 1 patent)

15. Carlos Cordon-Cardo (15 patents)

22 patents: Sort by Forward Citations

1. RE47439 - Method for manufacture of macrobeads (2019-06-17),

2. 9375448 - Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties (2016-06-28),

3. 9090866 - Method for manufacture of macrobeads (2015-07-28),

4. 8741637 - Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties (2014-06-03),

5. 8518394 - Seakem gold agarose beads comprising islets and coated with agarose (2013-08-27),

6. 7838291 - Entrapped stem cells and uses thereof (2010-11-23),

7. RE40555 - Preparation of agarose coated, solid agarose beads containing secretory cells (2008-10-27),

8. 7413871 - Scoring method for determining pancreas suitability for islet isolation (2008-08-19),

9. 7297331 - Beads containing restricted cancer cells producing material suppressing cancer cell proliferation (2007-11-20),

10. RE39542 - Preparation of agarose coated, solid agarose-collagen beads containing secretory cells (2007-04-02),

11. 7041504 - Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells (2006-05-09),

12. 6818230 - Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment (2004-11-16),

13. 6808705 - Agarose coated agarose beads containing cancer cells which produce cancer-cell proliferation-suppressing material (2004-10-26),

14. 6303151 - Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment (2001-10-16),

15. 5888497 - Agarose coated agarose beads containing cancer cells that produce (1999-03-30),

Company Overview

The Rogosin Institute, based in New York, is a leading research organization dedicated to advancing the understanding and treatment of cancer and kidney diseases. It specializes in translational research, bridging the gap between laboratory discoveries and clinical applications. The institute collaborates with various academic and medical institutions to develop innovative therapies and improve patient outcomes, focusing on personalized medicine and cutting-edge technologies in the biomedical field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#376 in New York, NY

#892 in New York

#15,037 in US

#28,782 in the World

New York, NY, United States of America

The Rogosin Institute

Forward Citations = 208

14 inventors:

Albert L Rubin (17 out of 25 patents)

Barry H Smith (16 out of 19 patents)

Kanti Jain (9 out of 10 patents)

4. Kurt Stenzel (7 out of 8 patents)

5. Lawrence Gazda (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Rogosin Institute. Retrieved from https://idiyas.com/company/rogosin-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…